Jenscare Scientific Co., Ltd. (HKG:9877)
9.66
+0.64 (7.10%)
At close: Mar 27, 2026
Jenscare Scientific Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 507.41 | 605.99 | 927.83 | 727.36 | 800.59 |
Short-Term Investments | - | 16.82 | 9.85 | 1.94 | 1.85 |
Trading Asset Securities | 20 | - | 166.44 | 97.75 | - |
Cash & Short-Term Investments | 527.41 | 622.81 | 1,104 | 827.05 | 802.44 |
Cash Growth | -15.32% | -43.59% | 33.50% | 3.07% | 129.88% |
Accounts Receivable | 6.84 | 9.31 | - | 0.68 | 0.53 |
Receivables | 6.84 | 9.31 | - | 0.68 | 0.53 |
Inventory | 27.12 | 35.65 | 28.13 | 9.89 | 4.67 |
Other Current Assets | 59.25 | 18.09 | 22.67 | 17.73 | 21.17 |
Total Current Assets | 620.61 | 685.86 | 1,155 | 855.36 | 828.81 |
Property, Plant & Equipment | 191.72 | 194.24 | 138.55 | 71.89 | 20.46 |
Long-Term Investments | 72.56 | 101.54 | - | 483.73 | 467.56 |
Other Intangible Assets | 5.19 | 4.01 | 4.14 | 4.19 | 2.39 |
Other Long-Term Assets | 6.16 | 41.92 | 29.49 | 16.16 | 22.14 |
Total Assets | 896.23 | 1,028 | 1,327 | 1,431 | 1,341 |
Accounts Payable | 25.15 | 12.51 | 16.94 | 11.75 | 8.66 |
Accrued Expenses | - | 12.68 | 18.73 | 15.94 | 11.58 |
Short-Term Debt | - | 4.36 | - | - | - |
Current Portion of Long-Term Debt | 28.04 | 11.66 | - | - | - |
Current Portion of Leases | 2.08 | 1.99 | 1.92 | 2.31 | 1.34 |
Current Unearned Revenue | - | 13.28 | 11.88 | 11.68 | 11.48 |
Other Current Liabilities | 50.6 | 7.72 | 9.22 | 15.06 | 16.65 |
Total Current Liabilities | 105.87 | 64.2 | 58.68 | 56.74 | 49.7 |
Long-Term Debt | 15.76 | 44.29 | 40.75 | - | - |
Long-Term Leases | 1.47 | 2.12 | 1.41 | 1.57 | 1.07 |
Total Liabilities | 123.11 | 110.61 | 100.84 | 58.3 | 50.77 |
Common Stock | 417.17 | 417.17 | 417.17 | 417.17 | 409.09 |
Additional Paid-In Capital | - | 1,238 | 1,238 | 1,215 | 1,034 |
Retained Earnings | - | -1,483 | -1,306 | -934.18 | -494.86 |
Treasury Stock | -0.36 | -132.29 | -5.04 | - | - |
Comprehensive Income & Other | 372.6 | 892.65 | 888.99 | 675.52 | 343.02 |
Total Common Equity | 789.41 | 931.76 | 1,233 | 1,373 | 1,291 |
Minority Interest | -16.28 | -14.81 | -6.62 | -0.26 | -0.16 |
Shareholders' Equity | 773.13 | 916.95 | 1,226 | 1,373 | 1,291 |
Total Liabilities & Equity | 896.23 | 1,028 | 1,327 | 1,431 | 1,341 |
Total Debt | 47.36 | 64.42 | 44.08 | 3.87 | 2.41 |
Net Cash (Debt) | 480.05 | 558.39 | 1,060 | 823.18 | 800.03 |
Net Cash Growth | -14.03% | -47.32% | 28.77% | 2.90% | 131.53% |
Net Cash Per Share | 1.13 | 1.37 | 2.54 | 2.25 | 2.36 |
Filing Date Shares Outstanding | 441.8 | 417.17 | 417.17 | 417.17 | 364.35 |
Total Common Shares Outstanding | 441.8 | 417.17 | 417.17 | 417.17 | 364.35 |
Working Capital | 514.74 | 621.65 | 1,096 | 798.62 | 779.11 |
Book Value Per Share | 1.79 | 2.23 | 2.96 | 3.29 | 3.54 |
Tangible Book Value | 784.22 | 927.75 | 1,229 | 1,369 | 1,288 |
Tangible Book Value Per Share | 1.78 | 2.22 | 2.95 | 3.28 | 3.54 |
Machinery | - | 45.5 | 41.84 | 34.94 | 16.82 |
Construction In Progress | - | 147.27 | 80.86 | 12.42 | 1.01 |
Leasehold Improvements | - | 15.05 | 13.8 | 12.92 | 11.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.